Published by Michele Maatouk on 10th October 2016
(ShareCast News) - Mylan shares surged in pre-market trade after the company said at the end of last week that it had agreed the terms of a $465m settlement with the US Department of Justice and other government agencies over how it charged Medicaid for its allergy shot pen EpiPen.
URL: http://www.digitallook.com/dl/news/story/25063671/...